Imeik Technology Development Co.,Ltd. (SZSE: 300896)
Health Care · Biotechnology · CN
CN¥95.00
+3.34% today · -47.3% 1Y
Imeik Technology Development Co.,Ltd. (SZSE: 300896) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.27B and employs 1,458 people.
Over the last twelve months the share price has lost 47.3%, trading between 83.36 and 182.00.
Tweenvest scores Imeik Technology Development Co.,Ltd. across four factors: quality 82/100, value 74/100, growth 95/100, dividend 61/100. Its strongest factor is growth.
300896 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.27B
- Revenue (TTM)
- $348.78M
- P/E
- 26.17
- EPS
- 3.63
- Dividend yield
- 1.68%
- Beta (5Y)
- 0.60
- 52-week high
- CN¥182.00
- 52-week low
- CN¥83.36
- Avg volume (3M)
- —
- Shares outstanding
- 301.43M
- Employees
- 1,458
- Next earnings
- —
About Imeik Technology Development Co.,Ltd.
Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
- ISIN
- CNE100004868
- Founded
- 2004
- Listed since
- Sep 28, 2020
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Dianthus Therapeutics, Inc.NasdaqCM: DNTH | $4.78B | $84.88 | -0.61% |
| Lin BioScience, Inc.TPEX: 6696 | $4.72B | NT$181.50 | -8.33% |
| Shanghai Junshi Biosciences Co., Ltd.SEHK: 1877 | $4.67B | HK$18.07 | -1.31% |
| Suzhou Zelgen Biopharmaceuticals Co., Ltd.SHSE: 688266 | $4.34B | CN¥110.00 | +0.96% |
| Relay Therapeutics, Inc.NasdaqGM: RLAY | $4.11B | $17.95 | -4.22% |
| Shanghai Henlius Biotech, Inc.SEHK: 2696 | $4.06B | HK$58.40 | +2.10% |
| Dizal (Jiangsu) Pharmaceutical Co., Ltd.SHSE: 688192 | $4.02B | CN¥58.01 | +2.76% |
| Tango Therapeutics, Inc.NasdaqGM: TNGX | $3.92B | $21.83 | -6.07% |
Figures last refreshed Oct 4, 2026.